Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases von MATHEW, Paul, THALL, Peter F, TU, Shi-Ming, MELUCH, Anthony A, SMITH, Lon, COHEN, Lorenzo, KIM, Sun-Jin, TRONCOSO, Patricia, FIDLER, Isaiah J, LOGOTHETIS, Christopher J, BUCANA, Corazon D, OH, William K, MORRIS, Michael J, JONES, Donnah M, JOHNSON, Marcella M, WEN, Sijin, PAGLIARO, Lance C, TANNIR, Nizar M

Volltext

Phase I Study of Concurrent Weekly Docetaxel and Repeated Samarium-153 Lexidronam in Patients With Castration-Resistant Metastatic Prostate Cancer von TU, Shi-Ming, MATHEW, Paul, WONG, Franklin C, JONES, Donnah, JOHNSON, Marcella M, LOGOTHETIS, Christopher J

Volltext

Randomized, Multicenter, Phase II Trial of Two Multicomponent Regimens in Androgen-Independent Prostate Cancer von MILLIKAN, Randall, THALL, Peter F, LEE, Sang-Joon, JONES, Donnah, CANNON, M. W, KUEBLER, J. Phillip, WADE, James III, LOGOTHETIS, Christopher J

Volltext

Phase II study of dolastatin-10 as first-line treatment for advanced colorectal cancer von SAAD, Everardo D, KRAUT, Eric H, HOFF, Paulo M, MOORE, Dennis F, JONES, Donnah, PAZDUR, Richard, ABBRUZZESE, James L

Volltext

Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms von KURZROCK, R, REDMAN, J, CABANILLAS, F, JONES, D, ROTHBERG, J, TALPAZ, M

Volltext

A Phase II trial of bryostatin‐1 for patients with metastatic renal cell carcinoma von Pagliaro, Lance, Daliani, Danai, Amato, Robert, Tu, Shi‐Ming, Jones, Donnah, Smith, Terry, Logothetis, Christopher, Millikan, Randall

Volltext

Strontium-89 combined with doxorubicin in the treatment of patients with androgen-independent prostate cancer von Tu, Shi-Ming, Delpassand, Ebrahim S., Jones, Donnah, Amato, Robert J., Ellerhorst, Julie, Logothetis, Christopher J.

Volltext